CAS RN: 106308-44-5

Rufinamide

Product Availability

Choose a grade to view its available package options.

3 package records3 with current stock1 grade group
Batch No.PackageAvailabilityInquiry
Batchno.20251019 100mg In stock Inquiry
Batchno.20260130 25mg In stock Inquiry
Batchno.20251222 500mg In stock Inquiry
  • Product code: SSC-008037
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 1g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 106308-44-5
Pack Size Recorded Purity Available Qty Ship From Inquiry
1g ≥95% 0 Out of Stock Beijing Inquiry

106308-44-5 / 1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide

Rufinamide | Inovelon | Banzel

Standard CAS: 106308-44-5 Multi CAS: Yes

Basic Information

CAS
106308-44-5
Multi CAS
Yes
Molecular Formula
C10H8F2N4O
Molecular Weight
238.190000
Exact Mass
238.066617
SMILES
C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F
InChI
InChI=1S/C10H8F2N4O/c11-7-2-1-3-8(12)6(7)4-16-5-9(10(13)17)14-15-16/h1-3,5H,4H2,(H2,13,17)
InChIKey
POGQSBRIGCQNEG-UHFFFAOYSA-N
Synonyms
Rufinamide Inovelon Banzel 1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide Cgp 33101

Computed Properties

Structural Parameters

Heavy atom count
17
Aromatic heavy atom count
11
Fraction Csp3
0.1
Rotatable bonds
3
H-bond acceptors
4
H-bond donors
1
Molar refractivity
54
TPSA
73.8

LogP / Solubility

WLOGP
0.7
MLOGP
0.62
XLogP3
0.7
Consensus LogP
0.67
Log S (ESOL)
-2.04
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.02
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.15
Class (SILICOS-IT)
Moderately soluble

ADME

GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.67

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5

Safety & Transport

Pictogram(s)
Irritant Health Hazard
Signal
Warning
GHS Hazard Statements
H336 (100%): May cause drowsiness or dizziness [Warning Specific target organ toxicity, single exposure; Narcotic effects] H351 (40%): Suspected of causing cancer [Warning Carcinogenicity] H361 (20%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] H361fd (20%): Suspected of damaging fertility; Suspected of damaging the unborn child [Warning Reproductive toxicity]
Precautionary Statement Codes
P203, P261, P271, P280, P304+P340, P318, P319, P403+P233, P405, and P501

Get In Touch

Contact Us